Related Experiment Video
Updated: Aug 20, 2026

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice
Published on: January 12, 2024
Advances in diabetes for the millennium: chronic microvascular complications of diabetes
1University of Oklahoma, Division of Endocrinology, Oklahoma City, Oklahoma, USA.
Abstract:
Hyperglycemia and microvascular complications of retinopathy, nephropathy, and neuropathy are shared by type 1 and type 2 diabetes. These complications seem to be uniquely associated with the diabetic state in humans and animals; they are not seen in nondiabetic humans or animals. Intervention trials aimed at achieving lower blood glucose levels as reflected in a lower HbA1c value have shown reductions in the rate of development of those complications when HbA1c is lower in one group compared with a matched group with less good control. Currently, 3 schools of thought have been championed to explain elevated blood glucose. Each is discussed here, as are interventions aimed at the various metabolic derangements rather than at correction of the hyperglycemia.
Insights
Type 1 and type 2 diabetes share hyperglycemia and microvascular complications. Lowering blood glucose (HbA1c) reduces complication rates, though three theories explain elevated blood glucose.
Area of Science:
- Endocrinology and Metabolism
- Diabetology
Background:
- Hyperglycemia is a hallmark of both type 1 and type 2 diabetes.
- Microvascular complications including retinopathy, nephropathy, and neuropathy are uniquely associated with the diabetic state.
Purpose of the Study:
- To review the shared microvascular complications in diabetes.
- To discuss current theories explaining hyperglycemia.
- To explore interventions targeting metabolic derangements versus solely correcting hyperglycemia.
Main Methods:
- Review of existing literature on diabetes complications and hyperglycemia.
- Discussion of intervention trial outcomes related to glycemic control (HbA1c).
- Analysis of different etiological theories for elevated blood glucose.
Main Results:
- Intervention trials demonstrate that lower HbA1c levels correlate with reduced rates of microvascular complication development.
- Three primary theories explaining hyperglycemia are currently debated.
- Focus is shifting towards interventions addressing underlying metabolic issues.
Conclusions:
- Glycemic control, measured by HbA1c, is crucial in mitigating diabetic microvascular complications.
- Understanding the diverse causes of hyperglycemia is essential for effective treatment strategies.
- Targeting metabolic derangements offers a promising therapeutic avenue beyond simple glucose lowering.
More Related Videos
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature
Published on: December 26, 2017
05:06Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy
Published on: July 14, 2023
Related Concept Videos
Diabetic Retinopathy
Complications of Diabetes Mellitus
Diabetic Nephropathy
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetic Foot Ulcer